English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse
  1. View item / 
  2. Item Summary

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium

MPS-Authors
/persons/resource/persons82210

Weiner,  January
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82029

Maertzdorf,  Jeroen
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82058

Mollenkopf,  Hans-Joachim
Core Facilities / Microarray, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons81969

Kaufmann,  Stefan H. E.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

Sci_Rep_2019_9_20362.pdf
(Publisher version), 4MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Weiner, J., Lewis, D. J. M., Maertzdorf, J., Mollenkopf, H.-J., Bodinham, C., Pizzoferro, K., et al. (2019). Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium. Scientific Reports, 9(1): 20362. doi:10.1038/s41598-019-56994-8.


Cite as: https://hdl.handle.net/21.11116/0000-0005-F335-D
Abstract
There is no abstract available